Coronary revascularisation in chronic kidney disease part II: Acute coronary syndromes

Journal of Renal Care

Volumn 36, Issue SUPPL. 1, 2010, Pages 118-126

  Seddon, Mike ^a   Curzen, Nick ^a  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Chronic; Coronary; Kidney; Revascularisation

Indexed keywords

ACUTE CORONARY SYNDROME; ARTICLE; CHRONIC KIDNEY FAILURE; FIBRINOLYTIC THERAPY; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MORTALITY; NURSING; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); STENT; SURVIVAL RATE; TRANSLUMINAL CORONARY ANGIOPLASTY;

ACUTE CORONARY SYNDROME; ANGIOPLASTY, BALLOON, CORONARY; GLOMERULAR FILTRATION RATE; HOSPITAL MORTALITY; HUMANS; KIDNEY FAILURE, CHRONIC; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STENTS; SURVIVAL RATE; THROMBOLYTIC THERAPY;

EID: 77952571592     PISSN: 17556678     EISSN: 17556686     Source Type: Journal    
DOI: 10.1111/j.1755-6686.2010.00157.x     Document Type: Article

References (43)

1. Al Suwaidi J., Reddan D.N., Williams K. et al 2002). Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation 106, 974 980.
2. Alexander K.P., Chen A.Y, Roe M.T.V. et al 2005). Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. JAMA 294, 3108 3116.
3. Anavekar N.S., McMurray J.J., Velazquez E.J. et al 2004). Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. New England Journal of Medicine 351, 1285 1295.
4. Anderson J.L., Adams CD., Antman E. M. et al 2007). ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 116, e148 e304.
5. Antman E.M., Hand M., Armstrong P.W. et al 2008). 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation 117, 296 329.
6. Beattie J.N., Soman S.S., Sandberg K.R. et al 2001). Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. American Journal of Kidney Diseases 37, 1191 1200.
7. Berger A.K., Duval S., Krumholz H.M. (2003). Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. Journal of the American College of Cardiology 42, 201 208.
8. Bonello L., De Labriolle A., Roy P. et al 2008). Impact of optimal medical therapy and revascularization on outcome of patients with chronic kidney disease and on dialysis who presented with acute coronary syndrome. The American Journal of Cardiology 102, 535 540.
9. Cannon C.P., Weintraub W.S., Demopoulos L.A. et al 2001). Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. The New England Journal of Medicine 344, 1879 1887.
10. De Freyter P.J., Serruys P.W., Unger F et al 2002). Bypass surgery versus stenting for the treatment of multivessel disease in patients with unstable angina compared with stable angina. Circulation 105, 2367 2372.
11. Eagle K.A., Lim M.J., Dabbous O.H. et al 2004). A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA 291, 2727 2733.
12. FRagmin and Fast Revascularisation in Coronary artery disease Investigators (1999). Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Lancet 354, 708 715.
13. Fernandez J.S., Sadaniantz B.T. Sadaniantz A. (2003). Review of antithrombotic agents used for acute coronary syndromes in renal patients. American Journal of Kidney Diseases 42, 446 455.
14. Fox K.A., Poole-Wilson P.A., Henderson R.A. et al 2002). Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina. Lancet 360, 743 751.
15. Gibson CM., Dumaine R.L., Gelfand E.V. et al 2004). Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13, 307 patients in five TIMI trials. European Heart Journal 25, 1998 2005.
16. Han J.H., Chandra A., Mulgund J. et al 2006). Chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes. The American Journal of Medicine 119, 248 254.
17. Herzog C.A., Littrell K., Arko C. et al 2007). Clinical characteristics of dialysis patients with acute myocardial infarction in the United States: a collaborative project of the United States Renal Data System and the National Registry of Myocardial Infarction. Circulation 116, 1465 1472.
18. Herzog C.A., Ma J.Z. Collins A.J. (1999). Long-term survival of dialysis patients receiving thrombolytic therapy for acute myocardial infarction in the US. Circulation, 100 (Suppl I 304.
19. Hobbach H.P., Gibson CM., Giugliano R.P. et al 2003). The prognostic value of serum creatinine on admission in fibrinolytic-eligible patients with acute myocardial infarction. Journal of Thrombosis and Thrombolysis 16, 167 174.
20. James S.K., Lindahl B., Siegbahn A. et al 2003). N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. Circulation 108, 275 281.
21. Januzzi J.L., Cannon C.P., Dibattiste P.M. et al 2002). Effects of renal insufficiency on early invasive management in patients with acute coronary syndromes (The TACTICS-TIMI 18 Trial). American Journal of Cardiology 90, 1246 1249.
22. Johnston N., Jernberg T, Lagerqvist B. et al 2006). Early invasive treatment benefits patients with renal dysfunction in unstable coronary artery disease. American Heart Journal 152, 1052 1058.
23. Keeley E.C., Boura J.A., Grines C.L. (2003a). Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361, 13 20.
24. Keeley E.C., Kadakia R., Soman S. et al 2003b). Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes. American Journal of Cardiology 92, 509 514.
25. Marenzi G., Assanelli E., Marana I. et al 2006). N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. The New England Journal of Medicine 354, 2773 2782.
26. Marenzi G., Lauri G., Assanelli E. et al 2004). Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. Journal of the American College of Cardiology 44, 1780 1785.
27. McCullough P.A. (2003). Why is chronic kidney disease the "spoiler" for cardiovascular outcomes? Journal of the American College of Cardiology 41, 725 728.
28. McCullough P.A., Sandberg K.R., Borzak S. et al 2002). Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease. Am Heart J 144, 226 232.
29. Medi C., Montalescot G., Budaj A. et al 2009). Reperfusion in patients with renal dysfunction after presentation with ST-segment elevation or left bundle branch block: GRACE (Global Registry of Acute Coronary Events). JACC Cardiovascular Interventions 2, 26 33.
30. Morrison D.A., Sethi G., Sacks J. et al 2001). Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study no 385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME). Journal of the American College of Cardiology 38, 143 149.
31. Mueller C., Neumann F.J., Perruchoud A.P. et al 2004). Renal function and long term mortality after unstable angina/non-ST segment elevation myocardial infarction treated very early and predominantly with percutaneous coronary intervention. Heart 90, 902 907. (Pubitemid 39005938)
32. Reddan D., Szczech L.A., O'Shea S. et al 2003a). Anticoagulation in acute cardiac care in patients with chronic kidney disease. American Heart Journal 145, 586 594.
33. Reddan D.N., O'Shea J.C, Sarembock I.J. et al 2003b). Treatment effects of eptifibatide in planned coronary stent implantation in patients with chronic kidney disease (ESPRIT Trial). The American Journal of Cardiology 91, 17 21.
34. Rodriguez A., Bernardi V, Navia J. et al 2001). Argentine randomized study: coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (ERACI II): 30-day and one-year follow-up results. ERACI II investigators. Journal of the American College of Cardiology 37, 51 58. (Pubitemid 32051717)
35. Rodriquez A.E., Baldi J., Fernandez Pereira C. et al 2005). Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II). Journal of the American College of Cardiology 46, 582 588.
36. Sadeghi H.M., Stone G.W., Grines C.L. et al 2003). Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation 108, 2769 2775.
37. Santopinto J.J., Fox K.A., Godlberg R.J. et al 2003). Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE). Heart 89, 1003 1008.
38. Schiele F., Legalery P., Didier K. et al 2006). Impact of renal dysfunction on 1-year mortality after acute myocardial infarction. American Heart Journal 151, 661 667. (Pubitemid 43290257)
39. Shlipak M.G., Heidenreich P.A., Noguchi H. et al 2002). Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Annals of Internal Medicine 137, 555 562.
40. Wong J.A., Goodman S.G., Yan R.T. et al 2009). Temporal management patterns and outcomes of non-ST elevation acute coronary syndromes in patients with kidney dysfunction. European Heart Journal 30, 549 557.
41. Wright R.S., Reeder G.S., Herzog C.A. et al 2002). Acute myocardial infarction and renal dysfunction: a high-risk combination. Annals of Internal Medicine 137, 563 570.
42. Yamaguchi J., Kasanuki H., Ishii Y. et al 2004). Prognostic significance of serum creatinine concentration for in-hospital mortality in patients with acute myocardial infarction who underwent successful primary percutaneous coronary intervention [from the Heart Institute of Japan Acute Myocardial Infarction (HIJAMI) Registry]. The American Journal of Cardiology 93, 1526 1528.
43. Zhang Z., Spertus J.A., Mahoney E.M. et al 2005). The impact of acute coronary syndrome on clinical, economic, and cardiac-specific health status after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: 1-year results from the Stent or Surgery (SoS) trial. American Heart Journal 150, 175 181.